Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 17.8B | 19.4B | 15.1B | 9.0B |
Cost of revenue | 12.5B | 14.3B | 11.3B | 7.2B |
Gross profit | 5.3B | 5.1B | 3.8B | 1.8B |
Operating expense | ||||
Research & development | — | 260.7M | 222.6M | 249.8M |
Selling general and admin | 1.5B | 574.7M | 419.0M | 418.4M |
Other operating expenses | — | -4.8M | 524.1M | -339.4M |
Operating income | 5.3B | 3.6B | 2.1B | 888.8M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 3.7B | 3.6B | 1.9B | 788.3M |
Tax provision | 144.8M | — | — | — |
Net income | 3.5B | 5.5B | 1.9B | 788.3M |
Basic EPS | 449.3 | — | 267 | 115 |
Diluted EPS | 449.3 | — | 267 | 115 |
Basic average shares | — | — | 7.1M | 6.9M |
Diluted average shares | — | — | 7.1M | 6.9M |
EBITDA | 5.3B | 4.2B | 2.4B | 1.3B |
Net income from continuing op. | — | 5.5B | 1.9B | 788.3M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |